Medical network - on March 27, according to the voice of the economy, the world of finance and economics newspaper medical equipment is an essential factor in modern medicine, because of the global frontier science and technology were pioneered in this area, so it has become the focus of national science and technology competition. Yesterday (25) for the "China medical equipment industry data release conference", the reporter understands, China's domestic market share of medical equipment and word of mouth has a degree of improvement, but it is still difficult to shake the foreign brand monopoly. 

 

Niche progress fast High-end equipment beyond difficult 

 

In recent 10 years, the average annual growth rate of medical equipment market in China is about 20%. The market do big at the same time, domestic equipment also had great progress. In the field of medical image, for example, has achieved the domestic 95% kinds of our products. A growing number of hospitals, new or replacement of the domestic equipment. In medical resources concentrated in Shanghai, for example, the Chinese medical association medical engineering branch of incoming chairman li bin, a Chinese brand the growth of large imaging equipment is enough to make people sit up and take notice. 

 

Li bin: "the growth rate reached 227%, magnetic resonance (NMR) the growth rate of 98%, almost double the growth, roll up to a year. It also suggests that in Shanghai area, to this kind of domestic medical apparatus and instruments, especially large imaging equipment began to accept." 

 

Also in Shanghai, medical beauty shadow lights, infusion pumps, such as medical equipment, domestic products market share of nearly half. In these niche, as it were, we have changed from "run" to "and" run. 

 

However, in the industry, our country still is given priority to with imported high-end medical equipment, domestic equipment market share of less than 15%. We often hear of computed tomography (CT), ultrasound imaging, such as vascular ZaoYingJi, magnetic resonance equipment, have been "GPS", that is, ge, philips, Siemens and other multinational company monopoly. 

 

A short board: lack of systemic solutions 

 

Yao has started and run, why it is hard to shake the monopoly of the multinational company? Commissioner of ministry of science and society development in biological medicine Zhang Zhaofeng, said a lack of systematic solution is the important reason for the domestic medical equipment is difficult to promote. 

 

Zhang Zhaofeng think: "the ultimate goal of medical equipment or in order to solve the clinical practical problems, in this respect we are have many products, but it doesn't really fit the doctor's actual demand, the future of a single product can't call it solutions, we must at the solution level can realize the ascension of the service." 

 

Board 2: lack of rigorous standard tracking 

 

Feed and national drug safety administration of medical device registration department inspection commissioner Wang Lanming is noticed, the lack of standards of rigorous tracking is also a large medical equipment manufacturing enterprises in China. 

 

Wang Lanming said: "I heard a enterprise with I say this, he said that our enterprises are very busy, you published every year so many standard, how could I know that you release the standard again? I tell him about the international big company has a team of laws and regulations standard, level is very high, this shows that the enterprise or planned economy thought, he thinks that development is the need to do, also need people to do production, sales is need more people to do, laws and regulations is helping to do it." 

 

Short 3: lack of clinical trial institution 

 

In addition to their own reasons, Wang Lanming also pointed out that the lack of clinical trial institution will restrict the application of domestic equipment. Learned, bear the medical instrument clinical trial institution in our country, it is by the state food and drug safety administration who planning commission for qualification authentication, then can work for clinical trials, the disadvantages of this mechanism is obvious. 

 

Wang Lanming said: "first, the clinical test units feel inadequate; the second because of the limited resources, so many clinical trial base certification, need to spend a lot of manpower and resources, we are looking to cancel clinical instrument clinical aptitude to put on record management, it will expand the scope of medical production enterprises to select the clinical test units and scope."